Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction

Background: Clinical guidelines recommend beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers, and statins for the secondary prevention of acute myocardial infarction (AMI). It is not clear whether variation in real-world practice reflects poor quality-of-care or a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Mary C., Chapman, Cole G., Chrischilles, Elizabeth A., Wilwert, June, Schneider, Kathleen M., Robinson, Jennifer G., Brooks, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680510/
https://www.ncbi.nlm.nih.gov/pubmed/36412823
http://dx.doi.org/10.3390/pharmacy10060147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680510/
https://www.ncbi.nlm.nih.gov/pubmed/36412823
http://dx.doi.org/10.3390/pharmacy10060147

Ejemplares similares